Design and rationale for the Japanese Registry of Rivaroxaban Effectiveness & Safety for the Prevention of Recurrence in Patients with Deep Vein Thrombosis and Pulmonary Embolism (J’xactly) study

INTRODUCTION: Rivaroxaban, a factor Xa inhibitor used as a direct oral anticoagulant, is beneficial over warfarin in terms of food–drug interactions and the need for therapeutic monitoring in patients with acute venous thromboembolism (VTE), including deep vein thrombosis and pulmonary embolism. Bec...

Descripción completa

Detalles Bibliográficos
Autores principales: Okumura, Yasuo, Fukuda, Ikuo, Nakamura, Mashio, Yamada, Norikazu, Takayama, Morimasa, Maeda, Hideaki, Yamashita, Takeshi, Ikeda, Takanori, Mo, Makoto, Yamazaki, Tsutomu, Hirayama, Atsushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6020936/
https://www.ncbi.nlm.nih.gov/pubmed/29934383
http://dx.doi.org/10.1136/bmjopen-2017-020286

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6020936/
https://www.ncbi.nlm.nih.gov/pubmed/29934383
http://dx.doi.org/10.1136/bmjopen-2017-020286

Ejemplares similares